A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma

NCT02649530 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped funding withdrawn

Conditions

Squamous Cell Carcinoma, Head And Neck

Interventions

DRUG: WNT974

Sponsor

University of Michigan Rogel Cancer Center